MDLN – medline inc. - class a common stock (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MDLN

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/15

07:47 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Zacks Research to a "hold" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Zacks Research to a "hold" rating.

Report

1/14

07:36 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.

Report

1/14

07:36 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Rothschild Redb to a "hold" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Rothschild Redb to a "hold" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Sanford C. Bernstein to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Sanford C. Bernstein to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at Baird R W to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at Baird R W to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at BMO Capital Markets to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at BMO Capital Markets to a "strong-buy" rating.

Report

1/13

05:44 am

mdln

Medline (NASDAQ:MDLN) was upgraded by analysts at BTIG Research to a "strong-buy" rating.

Low Report

Medline (NASDAQ:MDLN) was upgraded by analysts at BTIG Research to a "strong-buy" rating.

Report

1/12

12:00 pm

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $50.00 price target on the stock.

Low Report

Medline (NASDAQ:MDLN) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $50.00 price target on the stock.

Report

1/12

11:00 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $48.00 price target on the stock.

Low Report

Medline (NASDAQ:MDLN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $48.00 price target on the stock.

Report

1/12

10:04 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas. They set a "neutral" rating on the stock.

Low Report

Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas. They set a "neutral" rating on the stock.

Report

1/12

10:00 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating and a $38.00 price target on the stock.

Low Report

Medline (NASDAQ:MDLN) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating and a $38.00 price target on the stock.

Report

1/12

08:42 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $50.00 price target on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $50.00 price target on the stock.

Report

1/12

08:42 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.

Report

1/12

08:42 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $42.00 price target on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $42.00 price target on the stock.

Report

1/12

08:04 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at Rothschild & Co Redburn. They set a "neutral" rating and a $42.00 price target on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at Rothschild & Co Redburn. They set a "neutral" rating and a $42.00 price target on the stock.

Report

1/12

08:04 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $50.00 price target on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $50.00 price target on the stock.

Report

1/12

08:04 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at TD Cowen. They set a "buy" rating and a $46.00 price target on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at TD Cowen. They set a "buy" rating and a $46.00 price target on the stock.

Report

1/12

08:04 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at Mizuho. They set an "outperform" rating and a $48.00 price target on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at Mizuho. They set an "outperform" rating and a $48.00 price target on the stock.

Report

1/12

08:04 am

mdln

Medline (NASDAQ:MDLN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.

Medium Report

Medline (NASDAQ:MDLN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.